Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 240

1.

Scaling resolution of variant classification differences in ClinVar between 41 clinical laboratories through an outlier approach.

Harrison SM, Dolinksy JS, Chen W, Collins CD, Das S, Deignan JL, Garber KB, Garcia J, Jarinova O, Knight Johnson AE, Koskenvuo JW, Lee H, Mao R, Mar-Heyming R, McFaddin AS, Moyer K, Nagan N, Rentas S, Santani AB, Seppälä EH, Shirts BH, Tidwell T, Topper S, Vincent LM, Vinette K, Rehm HL; ClinGen Sequence Variant Inter-Laboratory Discrepancy Resolution Working Group.

Hum Mutat. 2018 Nov;39(11):1641-1649. doi: 10.1002/humu.23643.

PMID:
30311378
2.

Cancer stem cell pipeline flounders.

Garber K.

Nat Rev Drug Discov. 2018 Oct 12. doi: 10.1038/nrd.2018.157. [Epub ahead of print] No abstract available.

PMID:
30310232
3.

Alnylam launches era of RNAi drugs.

Garber K.

Nat Biotechnol. 2018 Sep 6;36(9):777-778. doi: 10.1038/nbt0918-777. No abstract available.

PMID:
30188543
4.

Predicting impacts of chemicals from organisms to ecosystem service delivery: A case study of endocrine disruptor effects on trout.

Forbes VE, Railsback S, Accolla C, Birnir B, Bruins RJF, Ducrot V, Galic N, Garber K, Harvey BC, Jager HI, Kanarek A, Pastorok R, Rebarber R, Thorbek P, Salice CJ.

Sci Total Environ. 2019 Feb 1;649:949-959. doi: 10.1016/j.scitotenv.2018.08.344. Epub 2018 Aug 28.

PMID:
30179823
5.

Xenophobia as a determinant of health: an integrative review.

Suleman S, Garber KD, Rutkow L.

J Public Health Policy. 2018 Sep 3. doi: 10.1057/s41271-018-0140-1. [Epub ahead of print]

PMID:
30177729
6.

Sensitivity analyses for simulating pesticide impacts on honey bee colonies.

Kuan AC, DeGrandi-Hoffman G, Curry RJ, Garber KV, Kanarek AR, Snyder MN, Wolfe KL, Purucker ST.

Ecol Modell. 2018 May 24;376:15-27. doi: 10.1016/j.ecolmodel.2018.02.010.

PMID:
30147220
7.

Assessing health systems in unrecognised states: lessons from the field.

Garber K, Aboulian A, Nalbandian D, Abrahamyan A, Danielyan A, Amirjanian A, Shekherdimian S.

BMJ. 2018 Aug 22;362:k3403. doi: 10.1136/bmj.k3403. No abstract available.

PMID:
30135089
8.

Erratum: Nature Biotechnology's academic spinouts of 2017.

Branca MA, Garber K, DeFrancesco L.

Nat Biotechnol. 2018 Aug 6;36(8):772. doi: 10.1038/nbt0818-772c. No abstract available.

PMID:
30080843
9.

Blood test may predict cancer immunotherapy benefit.

Garber K.

Science. 2018 Jun 29;360(6396):1387. doi: 10.1126/science.360.6396.1387. No abstract available.

PMID:
29954961
10.

A new cancer immunotherapy suffers a setback.

Garber K.

Science. 2018 May 11;360(6389):588. doi: 10.1126/science.360.6389.588. No abstract available.

PMID:
29748264
11.

Cytokine resurrection: engineered IL-2 ramps up immuno-oncology responses.

Garber K.

Nat Biotechnol. 2018 May 9;36(5):378-379. doi: 10.1038/nbt0518-378. No abstract available.

PMID:
29734296
12.

Nature Biotechnology's academic spinouts of 2017.

Branca MA, Garber K, DeFrancesco L.

Nat Biotechnol. 2018 Apr 5;36(4):297-306. doi: 10.1038/nbt.4121. No abstract available.

PMID:
29621217
13.

Tissue-agnostic cancer drug pipeline grows, despite doubts.

Garber K.

Nat Rev Drug Discov. 2018 Apr;17(4):227-229. doi: 10.1038/nrd.2018.6. Epub 2018 Mar 9. No abstract available.

PMID:
29520093
14.

Driving T-cell immunotherapy to solid tumors.

Garber K.

Nat Biotechnol. 2018 Mar 6;36(3):215-219. doi: 10.1038/nbt.4090. No abstract available.

PMID:
29509745
15.

A Framework for a Battlefield Trauma System for Civilians.

Garber K, Stewart BT, Burkle FM Jr, Kushner AL, Wren SM.

Ann Surg. 2018 Jul;268(1):30-31. doi: 10.1097/SLA.0000000000002691. No abstract available.

PMID:
29373367
16.

A framework for linking population model development with ecological risk assessment objectives.

Raimondo S, Etterson M, Pollesch N, Garber K, Kanarek A, Lehmann W, Awkerman J.

Integr Environ Assess Manag. 2018 May;14(3):369-380. doi: 10.1002/ieam.2024. Epub 2018 Feb 19.

PMID:
29271573
17.

First metabolic oncology inhibitor gets FDA green light, with record price tag.

Garber K.

Nat Biotechnol. 2017 Oct 11;35(10):895. doi: 10.1038/nbt1017-895. No abstract available.

PMID:
29020002
18.

Adenosine checkpoint agent blazes a trail, joins immunotherapy roster.

Garber K.

Nat Biotechnol. 2017 Sep 11;35(9):805-807. doi: 10.1038/nbt0917-805. No abstract available.

PMID:
28898225
19.

Attitudes Toward Morbidity and Mortality Conferences Among Medical and Surgical Pediatric Specialists in Armenia.

Rouch JD, Dawes AJ, Garber K, Sukhudyan B, Shekherdimian S.

JAMA Surg. 2017 Dec 1;152(12):1178-1180. doi: 10.1001/jamasurg.2017.2974. No abstract available.

20.

In a major shift, cancer drugs go 'tissue-agnostic'.

Garber K.

Science. 2017 Jun 16;356(6343):1111-1112. doi: 10.1126/science.356.6343.1111. No abstract available.

PMID:
28619894
21.

Industry 'road tests' new wave of immune checkpoints.

Garber K.

Nat Biotechnol. 2017 Jun 7;35(6):487-488. doi: 10.1038/nbt0617-487. No abstract available.

PMID:
28591107
22.

Erratum: Drugging the gut microbiome.

Garber K.

Nat Biotechnol. 2017 May 9;35(5):481. doi: 10.1038/nbt0517-481b. No abstract available.

PMID:
28486466
23.

Mechanistic modeling of insecticide risks to breeding birds in North American agroecosystems.

Etterson M, Garber K, Odenkirchen E.

PLoS One. 2017 May 3;12(5):e0176998. doi: 10.1371/journal.pone.0176998. eCollection 2017.

24.

Oncologists await historic first: a pan-tumor predictive marker, for immunotherapy.

Garber K.

Nat Biotechnol. 2017 Apr 11;35(4):297-298. doi: 10.1038/nbt0417-297a. No abstract available.

PMID:
28398313
25.

A framework for predicting impacts on ecosystem services from (sub)organismal responses to chemicals.

Forbes VE, Salice CJ, Birnir B, Bruins RJ, Calow P, Ducrot V, Galic N, Garber K, Harvey BC, Jager H, Kanarek A, Pastorok R, Railsback SF, Rebarber R, Thorbek P.

Environ Toxicol Chem. 2017 Apr;36(4):845-859. doi: 10.1002/etc.3720. Review.

26.

Worth the RISC?

Garber K.

Nat Biotechnol. 2017 Mar;35(3):198-202. doi: 10.1038/nbt.3810. Epub 2017 Feb 27. No abstract available.

PMID:
28244998
27.

Beyond a Moral Obligation: A Legal Framework for Emergency and Essential Surgical Care and Anesthesia.

Chawla KS, Rutkow L, Garber K, Kushner AL, Stewart BT.

World J Surg. 2017 May;41(5):1208-1217. doi: 10.1007/s00268-016-3866-6. Review.

PMID:
28180984
28.

Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.

LaLone CA, Villeneuve DL, Wu-Smart J, Milsk RY, Sappington K, Garber KV, Housenger J, Ankley GT.

Sci Total Environ. 2017 Apr 15;584-585:751-775. doi: 10.1016/j.scitotenv.2017.01.113. Epub 2017 Jan 24. Review.

29.

Alnylam terminates revusiran program, stock plunges.

Garber K.

Nat Biotechnol. 2016 Dec 7;34(12):1213-1214. doi: 10.1038/nbt1216-1213. No abstract available.

PMID:
27926717
30.

Reassessment of Genomic Sequence Variation to Harmonize Interpretation for Personalized Medicine.

Garber KB, Vincent LM, Alexander JJ, Bean LJH, Bale S, Hegde M.

Am J Hum Genet. 2016 Nov 3;99(5):1140-1149. doi: 10.1016/j.ajhg.2016.09.015. Epub 2016 Oct 27.

31.

Big win possible for Ionis/Biogen antisense drug in muscular atrophy.

Garber K.

Nat Biotechnol. 2016 Oct 11;34(10):1002-1003. doi: 10.1038/nbt1016-1002. No abstract available.

PMID:
27727217
32.

Implementing school based telehealth for children with medical complexity.

Cormack CL, Garber K, Cristaldi K, Edlund B, Dodds C, McElligott L.

J Pediatr Rehabil Med. 2016 Sep 2;9(3):237-40. doi: 10.3233/PRM-160385.

PMID:
27612084
33.

Erratum: No longer going to waste.

Garber K.

Nat Biotechnol. 2016 Aug 9;34(8):888. doi: 10.1038/nbt0816-888b. No abstract available.

PMID:
27504779
34.

Cancer anabolic metabolism inhibitors move into clinic.

Garber K.

Nat Biotechnol. 2016 Aug 9;34(8):794-5. doi: 10.1038/nbt0816-794. No abstract available.

PMID:
27504761
35.

Two pioneering osteoporosis drugs finally approach approval.

Garber K.

Nat Rev Drug Discov. 2016 Jun 30;15(7):445-6. doi: 10.1038/nrd.2016.132. No abstract available.

PMID:
27357010
36.

Variants of uncertain significance in newborn screening disorders: implications for large-scale genomic sequencing.

Narravula A, Garber KB, Askree SH, Hegde M, Hall PL.

Genet Med. 2017 Jan;19(1):77-82. doi: 10.1038/gim.2016.67. Epub 2016 Jun 16.

PMID:
27308838
37.

Bristol-Myers Squibb locks into novel autoimmune strategy.

Garber K.

Nat Biotechnol. 2016 Jun 9;34(6):577-9. doi: 10.1038/nbt0616-577. No abstract available.

PMID:
27281396
38.

No longer going to waste.

Garber K.

Nat Biotechnol. 2016 May 6;34(5):458-61. doi: 10.1038/nbt.3557. No abstract available. Erratum in: Nat Biotechnol. 2016 Aug 9;34(8):888.

PMID:
27153267
39.

Participatory Genomic Testing as an Educational Experience.

Garber KB, Hyland KM, Dasgupta S.

Trends Genet. 2016 Jun;32(6):317-320. doi: 10.1016/j.tig.2016.03.008. Epub 2016 Apr 22. Review.

PMID:
27117243
40.

Natural killer cells blaze into immuno-oncology.

Garber K.

Nat Biotechnol. 2016 Mar;34(3):219-20. doi: 10.1038/nbt0316-219. No abstract available.

PMID:
26963532
41.

Alternative Therapeutic Approach in the Treatment of Oral Pyogenic Granuloma.

Bugshan A, Patel H, Garber K, Meiller TF.

Case Rep Oncol. 2015 Nov 14;8(3):493-7. doi: 10.1159/000441839. eCollection 2015 Sep-Dec.

42.

Participation in the Adoption Mentoring Partnership: Mentors' Experiences of Ethnic Identity.

Garber KJ, French QY, Grotevant HD.

New Dir Child Adolesc Dev. 2015 Dec;2015(150):77-89. doi: 10.1002/cad.20123.

PMID:
26650810
43.

Tumor macrophage target fuels $1.7-billion deal.

Garber K.

Nat Biotechnol. 2015 Dec 9;33(12):1222. doi: 10.1038/nbt1215-1222. No abstract available.

PMID:
26650003
44.

Predictive biomarkers for checkpoints, first tests approved.

Garber K.

Nat Biotechnol. 2015 Dec 9;33(12):1217-1218. doi: 10.1038/nbt1215-1217. No abstract available.

PMID:
26649999
45.

CELL BIOLOGY. Protein 'drops' may seed brain disease.

Garber K.

Science. 2015 Oct 23;350(6259):366-7. doi: 10.1126/science.350.6259.366. No abstract available.

PMID:
26494738
46.

Microaggressions, Feelings of Difference, and Resilience Among Adopted Children with Sexual Minority Parents.

Farr RH, Crain EE, Oakley MK, Cashen KK, Garber KJ.

J Youth Adolesc. 2016 Jan;45(1):85-104. doi: 10.1007/s10964-015-0353-6. Epub 2015 Sep 15.

PMID:
26374241
47.

RIKEN suspends first clinical trial involving induced pluripotent stem cells.

Garber K.

Nat Biotechnol. 2015 Sep;33(9):890-1. doi: 10.1038/nbt0915-890. No abstract available.

PMID:
26348942
48.

Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae.

Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PN.

Antimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.

49.

Cancer's copper connections.

Garber K.

Science. 2015 Jul 10;349(6244):129. doi: 10.1126/science.349.6244.129. No abstract available.

PMID:
26160924
50.

BIOMEDICINE. Targeting copper to treat breast cancer.

Garber K.

Science. 2015 Jul 10;349(6244):128-9. doi: 10.1126/science.349.6244.128. No abstract available.

PMID:
26160923

Supplemental Content

Loading ...
Support Center